The Editorial Board is again pleased to offer its warmest congratulations to the winner of the 2023 Cushing’s Hub Competition, Dr Shobana Athimulam, Assistant Professor of Medicine, Henry Ford Health, Detroit, MI, USA whose excellent Interactive Clinical Case is now available online.
Dr Athimulam clearly explains the evaluation of adrenal incidentalomas, which are present in approximately 5% of individuals subject to cross-sectional abdominal imaging. Given that up to half of these lesions are functional, widespread exposure to chronic low-level cortisol excess and its link to serious co-morbidities such as hypertension, dyslipidaemia, pre-diabetes, and osteopenia, is a major concern, at both the individual and population level.
To learn more about the challenges associated with mild autonomous cortisol secretion, including work-up, assessment of related comorbidities, and personalised treatment plans, click below.
The Cushing’s Hub Editorial Board is delighted to announce the release of the webcast from the second event in the Cushing’s Hub Webinar Series – Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS) – held on Tuesday 24 October.
Chaired by Dr Susan M. Webb, Barcelona, Spain, this webcast sees panelists Assoc. Prof. Iacopo Chiodini, Milan, Italy and Dr Irina Bancos, Rochester, MN, USA, discuss, using a case-centred approach, the clinical management of low-grade excessive cortisol secretion and take questions from the audience.
The live event, and webcast, Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS), 24/10/23, have been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credit (ECMEC®).
This editorial looks at the impact of different adrenal hormone subtypes on frailty in patients with adrenal adenomas – is ‘NFAT’ the correct term?
This case study ꟷ the Cushing’s Hub Clinical Case Competition 2023 winning entry ꟷ looks at the clinical evaluation and management of MACS ranging from the assessment of adrenal incidentalomas to the development of an individual treatment plan.
Children and adolescents with ectopic adrenocorticotropic hormone syndrome have a different etiological profile to that of adults, suggests a systematic review of the literature published in the European Journal of Endocrinology in October 2023.